Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren add-on to valsartan + hydrochlorothiazide in patients with diabetes and hypertension
2004-004794-28Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Aliskiren add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change from baseline in mean sitting diastolic blood pressure. Started Mar 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-004794-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004794-28.